1. Hunt FA, Rylatt DB, Hart RA, Bundesen PG (1985) Serum crosslinked fibrin (XDP) and fibrinogen/fibrin degradation products (FDP) in disorders associated with activation of the coagulation of fibrinolytic systems. BJH 60(4):715–722
2. Adam SS, Key NS, Greenberg CS (2009) D-dimer antigen: current concepts and future prospects. Blood 113(13):2878–2887
3. Brown BA (1980) Coagulation. In: Hematology, 3rd edn. Lea & Febiger, Philadelphia, PA. p 115
4. Francis CW, Marder VJ (1994) Physiologic regulation and pathologic disorders of fibrinolysis. In: Colman RW, Hirsch J, Marder VJ (eds) Hemostasis and thrombosis: basic principles and clinical practice, 3rd edn. TB Lippincott Company, Philadelphia, PA, pp 1081–1083
5. Laffan M, Manning R (2006) Investigation of haemostasis. In: Lewis SM, Bain BJ, Bates I (eds) Dacie & Lewis practical haematology, 10th edn. Churchill Livingstone Elsevier, Edinburgh, p 386